Unveiling Yiyi Fuzi Baijiang powder: Microecological and network pharmacology approach to ulcerative colitis treatment

Figure 2 Results of network pharmacology analysis. A: Protein-protein interaction network of the common targets according to STRING; B: Common genes network according to degree value analyzed by Cytoscape software; C: Key compound-potential targets network according to degree value analyzed by Cytoscape software; D: Location of the top 17 vital pathway in Kyoto Encyclopedia of Genes and Genomes pathway by Database for Annotation Visualization and Integrated Discovery database according to the common target; E: Gene Ontology functional enrichment analysis; F: Traditional Chinese medicine-compound-target-pathway-disease network according to degree value analyzed by Cytoscape software. TNF: Tumor necrosis factor; NOD: Nucleotide-binding oligomerization domain; PI3K: Phosphatidylinositol 3-kinase; Akt: Protein kinase B; HTLV-1: Human T lymphotropic virus type 1; FDR: False discovery rate; BP: Biological processes; CC: Cell composition; MF: Molecular function; FZ: Fuzi; UC: Ulcerative colitis; YYR: Yiyiren; BJC: Baijiangcao.